AsttraZeneca Pharmaceuticals LP

Wilmington, DE, United States

1

Total Recalls

0

Class I Recalls

1

Ongoing Recalls

Recalls by AsttraZeneca Pharmaceuticals LP

FDA Drug Class II Ongoing

Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, M

May 14, 2025 AsttraZeneca Pharmaceuticals LP a) 807,837 canisters; b) 235,698 canisters units